Gene · 3482
Papers4,462
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 4,462
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epididymis cell atlas in a patient with a sex development disorder and a novel NR5A1 gene mutation. | Asian J Androl | 2023 | 35546286 | PubTator, text mining | PubMed |
| Systematic characterization of extracellular glycoproteins using mass spectrometry. | Mass Spectrom Rev | 2023 | 34047389 | PubTator, text mining | PubMed |
| Regulation of Endosomal Sorting and Maturation by ER-Endosome Contact Sites. | Contact (Thousand Oaks) | 2022 | 37366507 | PubTator, text mining | PubMed |
| Pompe Disease: a Clinical, Diagnostic, and Therapeutic Overview. | Curr Treat Options Neurol | 2022 | 36969713 | PubTator, text mining | PubMed |
| Editorial: The role of the IGF axis in tumorigenesis and cancer treatment: From genes to metabolites. | Front Endocrinol (Lausanne) | 2022 | 36866167 | PubTator, text mining | PubMed |
| On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications. | Front Oncol | 2022 | 36844925 | PubTator, text mining | PubMed |
| Targeting BRAF V600E in metastatic colorectal cancer: where are we today? | Ecancermedicalscience | 2022 | 36819812 | PubTator, text mining | PubMed |
| Novel insights into the immune cell landscape and gene signatures in autism spectrum disorder by bioinformatics and clinical analysis. | Front Immunol | 2022 | 36761165 | PubTator, text mining | PubMed |
| Therapeutic advances in overcoming intrauterine growth restriction induced metabolic syndrome. | Front Pediatr | 2022 | 36714657 | PubTator, text mining | PubMed |
| Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumors. | Front Oncol | 2022 | 36713521 | PubTator, text mining | PubMed |
| Defining the altered glycoproteomic space of the early secretory pathway by class I mannosidase pharmacological inhibition. | Front Mol Biosci | 2022 | 36699698 | PubTator, text mining | PubMed |
| Actinomycetes-derived imine reductases with a preference towards bulky amine substrates. | Commun Chem | 2022 | 36697820 | PubTator, text mining | PubMed |
| Protein-Targeted Degradation Agents Based on Natural Products. | Pharmaceuticals (Basel) | 2022 | 36678543 | PubTator, text mining | PubMed |
| Systems biology and in silico-based analysis of PCOS revealed the risk of metabolic disorders. | Heliyon | 2022 | 36619413 | PubTator, text mining | PubMed |
| Current Trends and Approaches to the Search for Genetic Determinants of Aging and Longevity. | Russ J Genet | 2022 | 36590179 | PubTator, text mining | PubMed |
| Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism. | Front Endocrinol (Lausanne) | 2022 | 36589856 | PubTator, text mining | PubMed |
| Signaling pathways of adipose stem cell-derived exosomes promoting muscle regeneration. | Chin Med J (Engl) | 2022 | 36583914 | PubTator, text mining | PubMed |
| Riddle of the Sphinx: facts and evidence regarding the link between mental stress and tumor occurrence and development. | Chin Med J (Engl) | 2022 | 36580651 | PubTator, text mining | PubMed |
| The Bioavailability of Glycyrrhizinic Acid Was Enhanced by Probiotic Lactobacillus rhamnosus R0011 Supplementation in Liver Fibrosis Rats. | Nutrients | 2022 | 36558437 | PubTator, text mining | PubMed |
| TLR4/CD14/MD2 Revealed as the Limited Toll-like Receptor Complex for Chlamydia trachomatis-Induced NF-κB Signaling. | Microorganisms | 2022 | 36557742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3482/papers?page=27